News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

DPDT Anticancer Activity in Human Colon Cancer HCT116 Cells

News

June 26, 2023
PRESS RELEASE: On June 21, 2023, a new research paper was published in Oncotarget, entitled, “Diphenyl ditelluride anticancer activity and DNA topoisomerase I poisoning in human colon cancer HCT116 cells.” continue reading »

Cancer Cell Repopulation After Therapy: Which is the Mechanism?

News

June 23, 2023
PRESS RELEASE: On June 1, 2023, a new research perspective was published in Oncoscience, entitled, “Cancer cell repopulation after therapy: which is the mechanism?” continue reading »

Targeting GITR in cancer immunotherapy – there is no perfect knowledge

News

June 21, 2023
PRESS RELEASE: On June 19, 2023, a new research perspective was published in Oncotarget, entitled, “Targeting GITR in cancer immunotherapy – there is no perfect knowledge.” continue reading »

Precious1GPT: Multimodal Transfer Learning for Aging Clock Development and Target Discovery

Aging

June 20, 2023
PRESS RELEASE: A new research paper was published in Aging's Volume 15, Issue 11, entitled, “Precious1GPT: multimodal transformer-based transfer learning for aging clock development and feature importance analysis for aging and age-related disease target discovery.” continue reading »

Metformin’s Role in Preventing Metabolic Syndrome during Androgen Deprivation Therapy: A Phase II Study

News

June 20, 2023
PRESS RELEASE: On June 19, 2023, a new research paper was published in Oncotarget, entitled, “Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer.” continue reading »